A Study of an IDH1m Inhibitor in Participants with IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-517923-38-00

Acronym

S095031-218

Enrollment

Registered

2025-11-24

Start date

2025-12-10

Completion date

Unknown

Last updated

2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Newly diagnosed and/or previously treated IDH1-mutated malignancies

None listed

Sex/Gender

All

Age

18 Years to No maximum

Czechia, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026